I was excited by the Theranos idea. I was excited by the
uBiome idea (and even attempted to be a customer!). But obviously both went poof. I want to know how this could happen. What are the bigger problems in the industry? If you think these 2 are rare examples, I would call them minor compared to many of the companies in the space.
Common factors seem to be: secrecy, and sticking to the old
mindset of #ImaginaryProperty business models (patents,
ndas, copyrights, et cetera).
I want to see the visions espoused by Theranos and uBiome
come to fruition. There are *not* a lot of great examples
of good biotech companies to emulate. AFAIK, there hasn't
been a "don't be evil" moment in biotech.
Some biotech/healthcare company needs to come out and say
"fck the old ways, they aren't working—Americans are not
healthier, costs are up, and we still haven't solved
cancer", and take a radical new approach of openness,
collaboration, and forget about the abosolute horsesht
practices of secrecy, #imaginaryproperty, and putting
patients far down on the list of priorities.
Common factors seem to be: secrecy, and sticking to the old mindset of #ImaginaryProperty business models (patents, ndas, copyrights, et cetera).
I want to see the visions espoused by Theranos and uBiome come to fruition. There are *not* a lot of great examples of good biotech companies to emulate. AFAIK, there hasn't been a "don't be evil" moment in biotech.
Some biotech/healthcare company needs to come out and say "fck the old ways, they aren't working—Americans are not healthier, costs are up, and we still haven't solved cancer", and take a radical new approach of openness, collaboration, and forget about the abosolute horsesht practices of secrecy, #imaginaryproperty, and putting patients far down on the list of priorities.